Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00487
|
|||||
| Drug Name |
Suvorexant
|
|||||
| Synonyms |
((7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone; (R)-(4-(5-Chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone; 081L192FO9; 1030377-33-3; BELSOMRA; C23H23ClN6O2; CHEBI:82698; CHEMBL1083659; MK 4305; MK-4305; MK4305; Suvorexant; Suvorexant (MK-4305); UNII-081L192FO9; [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H23ClN6O2
|
|||||
| Canonical SMILES |
CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl
|
|||||
| InChI |
InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1
|
|||||
| InChIKey |
JYTNQNCOQXFQPK-MRXNPFEDSA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 450.9 | Topological Polar Surface Area | 80.3 | ||
| Heavy Atom Count | 32 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
4.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103755866
, 104153062
, 134348113
, 135267387
, 135650615
, 136946578
, 138669889
, 141618580
, 152258025
, 152258268
, 160647104
, 163312227
, 164044652
, 171061162
, 175266695
, 176245483
, 184816450
, 198993974
, 215784570
, 223377940
, 223447420
, 223620167
, 223704064
, 225372552
, 227781057
, 248624194
, 249822123
, 250214353
, 251963163
, 252062692
, 252211821
, 252215820
, 252442778
, 252473529
, 56264110
, 57493879
, 99431637
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.